Pfizer reports no 'drug hangover' with Lyrica
This article was originally published in Scrip
Executive Summary
Pfizer has reported data showing that it is possible to discontinue treatment with its blockbuster pain/anxiety drug Lyrica (pregabalin) with relatively few withdrawal symptoms.